Skip to main content
OpenTrials

Clinical trial condition

Recurrent Gastric Adenocarcinoma

Explore clinical trials studying Recurrent Gastric Adenocarcinoma. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Recurrent Gastric Adenocarcinoma trial results

Completed

IRX-2, Cyclophosphamide, and Pembrolizumab in Treating Participants With Recurrent or Metastatic Gastric or Gastroesophageal Junction Cancer

NCT03918499

Conditions
Clinical Stage IV Gastric Cancer AJCC v8, Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage IVA Gastric Cancer AJCC v8, +15 more
Locations
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • City of Hope Medical Center Duarte, California, United States
  • Texas Oncology at Baylor Charles A Sammons Cancer Center Dallas, Texas, United States
View Trial Details

Related conditions